Illinois Department of Commerce and Economic Opportunity approves development of new research park in North Chicago

NewsGuard 100/100 Score

The Illinois Department of Commerce and Economic Opportunity recently approved the expansion of a state enterprise zone, designed to stimulate economic growth and community revitalization at the local level, to include North Chicago, IL-based

Economic incentives offered to operating companies within the Waukegan-North Chicago Enterprise Zone will help the university attract investment in its new

"The research park will help our university move its science and intellectual property out of the lab and into the marketplace to improve human health, including the health of our local populations burdened with significant health disparities," said RFU President and CEO Dr. K. Michael Welch. "It will also improve the health of our local and regional economy and bring opportunities to nearby low-income neighborhoods that are struggling to recover from the loss of industry and decades of economic decline."

Nonprofit Lake County Partners estimates that the four-story building, which could be part of a multiphase development, will create an estimated 500 direct and related jobs and a total economic regional impact of $117 million per year.

The expansion is rooted in a public-private partnership that in addition to Rosalind Franklin University includes the City of North Chicago, Lake County, Illinois Department of Commerce and Economic Opportunity and developer not-for-profit TUFF, which worked with Gateway Development to complete the $53 million financing for the project.

"It's an important project for the university and Lake County," said Lake County Board Chair Aaron Lawlor. "Investments in cutting-edge facilities like this help us build on the county's strength in the life sciences and provide greater opportunities for collaboration, innovation and economic development."

"Working together, we're placing the science park on solid financial footing so that it can benefit RFU, its local communities and region for generations to come," said RFU Executive Vice President of Research Ronald Kaplan. "We feel particularly driven to study diseases that affect our local population, including cancer, diabetes and Alzheimer's. We can't move our science forward and leave our community behind."

Strong support from local, state and federal elected officials and industry leaders has helped fuel the project. North Chicago Mayor Leon Rockingham Jr. said the city and RFU maintain a productive partnership.

"Our support for the expansion of our enterprise zone demonstrates our commitment to the university, its scientific research and the economic growth and development of our community," Rockingham said.

The new building, to be completed by summer 2019, will feature state-of-the-art laboratories meeting and office space for faculty and commercial startups and national and international biotech and healthcare firms. It will include the Brain Science Institute and its three disease-focused research centers, in addition to three centers dedicated to genetic diseases, cancer cell biology and proteomics and molecular therapeutics. Industry collaborators will work in dedicated space on each floor of the building.

Chicago-based brokerage firm

"The life sciences are a core part of our history and our economy," said Kevin Considine, Lake County Partners president and CEO. "Pharmaceuticals, medical products, technology and health care are in Lake County's DNA and we're ready to assist businesses in these industries through our strong network of stakeholders, which includes Rosalind Franklin University.

Source: https://www.rosalindfranklin.edu/news/public-private-partnership-fuels-development-of-new-research-park/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings